Working… Menu
Trial record 1 of 26 for:    astra zeneca strong
Previous Study | Return to List | Next Study

An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies. (STRONG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03084471
Recruitment Status : Recruiting
First Posted : March 21, 2017
Last Update Posted : September 20, 2019
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 26, 2023
Estimated Study Completion Date : March 26, 2023